ZTS FY 2018 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5.8B+9.8% YoY

Gross Profit

$3.8B65.2% margin

Operating Income

$1.9B32.3% margin

Net Income

$1.4B24.5% margin

EPS (Diluted)

$2.93

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.5B

Stock-Based Comp.

$53M

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$8.6B

Stockholders' Equity

$2.2B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.8B	$5.3B	+9.8%
Gross Profit	$3.8B	$3.4B	+10.3%
Operating Income	$1.9B	$1.7B	+8.9%
Net Income	$1.4B	$864M	+65.3%